These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32325740)

  • 1. Plant-Produced N-glycosylated Ag85A Exhibits Enhanced Vaccine Efficacy Against
    Kim H; Kwon KW; Park J; Kang H; Lee Y; Sohn EJ; Hwang I; Eum SY; Shin SJ
    Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32325740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis.
    Kim WS; Kim JS; Kim HM; Kwon KW; Eum SY; Shin SJ
    Sci Rep; 2018 Sep; 8(1):14411. PubMed ID: 30258084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine efficacy of a
    Kwon KW; Choi HH; Han SJ; Kim JS; Kim WS; Kim H; Kim LH; Kang SM; Park J; Shin SJ
    FASEB J; 2019 May; 33(5):6483-6496. PubMed ID: 30753099
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis.
    Jeon BY; Kim SC; Eum SY; Cho SN
    Microbes Infect; 2011 Mar; 13(3):284-90. PubMed ID: 21093603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice.
    Sun L; Yuan Q; Xu T; Yao L; Feng J; Ma J; Wang L; Lv C; Wang D
    Biotechnol Lett; 2017 Aug; 39(8):1159-1166. PubMed ID: 28470626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the fusion design and immunization route on the immunogenicity of Ag85A-Mtb32 in adenoviral vectored tuberculosis vaccine.
    Zhang Y; Feng L; Li L; Wang D; Li C; Sun C; Li P; Zheng X; Liu Y; Yang W; Niu X; Zhong N; Chen L
    Hum Vaccin Immunother; 2015; 11(7):1803-13. PubMed ID: 26076321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and Vaccine Potential of InsB, an ESAT-6-Like Antigen Identified in the Highly Virulent
    Kim WS; Kim H; Kwon KW; Cho SN; Shin SJ
    Front Microbiol; 2019; 10():220. PubMed ID: 30809214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
    Wang D; Xu J; Feng Y; Liu Y; Mchenga SS; Shan F; Sasaki J; Lu C
    Vaccine; 2010 Apr; 28(18):3134-42. PubMed ID: 20197133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic effects of Mycobacterium tuberculosis rv3407 DNA vaccine in mice.
    Liang Y; Zhao Y; Bai X; Xiao L; Yang Y; Zhang J; Wang L; Cui L; Wang T; Shi Y; Zhao W; Wu X
    Autoimmunity; 2018 Dec; 51(8):417-422. PubMed ID: 30632804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
    Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
    Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
    Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
    J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD226 as a genetic adjuvant to enhance immune efficacy induced by Ag85A DNA vaccination.
    Li Y; Yang F; Zhu J; Sang L; Han X; Wang D; Shan F; Li S; Sun X; Lu C
    Int Immunopharmacol; 2015 Mar; 25(1):10-8. PubMed ID: 25582686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cellular immune response elicited by a DNA vaccine fused with Ub against Mycobacterium tuberculosis.
    Wang QM; Tang Y; Lei ChX; Shi FZ; Liu QH
    Scand J Immunol; 2012 Aug; 76(2):123-30. PubMed ID: 22540309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium tuberculosis multistage antigens confer comprehensive protection against pre- and post-exposure infections by driving Th1-type T cell immunity.
    Ma J; Tian M; Fan X; Yu Q; Jing Y; Wang W; Li L; Zhou Z
    Oncotarget; 2016 Sep; 7(39):63804-63815. PubMed ID: 27566581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG7909 adjuvant enhanced immunogenicity efficacy in mice immunized with ESAT6-Ag85A fusion protein, but does not confer significant protection against Mycobacterium tuberculosis infection.
    Hu S; Chen H; Ma J; Chen Q; Deng H; Gong F; Huang H; Shi C
    J Appl Microbiol; 2013 Nov; 115(5):1203-11. PubMed ID: 23902541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Adjuvant MTOM Mediates
    Yu Q; Wang X; Fan X
    Front Immunol; 2017; 8():585. PubMed ID: 28572807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis Rv3628 drives Th1-type T cell immunity via TLR2-mediated activation of dendritic cells and displays vaccine potential against the hyper-virulent Beijing K strain.
    Kim WS; Kim JS; Cha SB; Kim H; Kwon KW; Kim SJ; Han SJ; Choi SY; Cho SN; Park JH; Shin SJ
    Oncotarget; 2016 May; 7(18):24962-82. PubMed ID: 27097115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.